Engineering of an ene-reductase for producing the key intermediate of antiepileptic drug Brivaracetam

[1]  R. Bhosale,et al.  Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug , 2022, ACS omega.

[2]  W. Kroutil,et al.  Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods. , 2021, Chemical reviews.

[3]  F. Parmeggiani,et al.  “A Study in Yellow”: Investigations in the Stereoselectivity of Ene‐Reductases , 2021, Chembiochem : a European journal of chemical biology.

[4]  Yajie Wang,et al.  Directed Evolution: Methodologies and Applications. , 2021, Chemical reviews.

[5]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[6]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[7]  Jinhyun Kim,et al.  Solar-Powered Whole-Cell P450 Catalytic Platform for C-Hydroxylation Reactions. , 2021, ChemSusChem.

[8]  B. Hribar-Lee,et al.  Effect of Buffer on Protein Stability in Aqueous Solutions: A Simple Protein Aggregation Model , 2021, The journal of physical chemistry. B.

[9]  N. Adir,et al.  NADPH performs mediated electron transfer in cyanobacterial-driven bio-photoelectrochemical cells , 2020, iScience.

[10]  Zaiyou Yang,et al.  Identification, characterization, synthesis and strategy for minimization of potential impurities observed in the synthesis of brivaracetam , 2020, Tetrahedron.

[11]  Jiang Pan,et al.  Evolution of Glucose Dehydrogenase for Cofactor Regeneration in Bioredox Processes with Denaturing Agents , 2020, Chembiochem : a European journal of chemical biology.

[12]  Christin Peters,et al.  Novel Old Yellow Enzyme Subclasses , 2019, Chembiochem : a European journal of chemical biology.

[13]  Nigel S. Scrutton,et al.  Discovery, Characterisation, Engineering and Applications of Ene Reductases for Industrial Biocatalysis. , 2018, ACS catalysis.

[14]  Xuezheng Sun,et al.  The epidemiology of drug‐resistant epilepsy: A systematic review and meta‐analysis , 2018, Epilepsia.

[15]  P. Ferraboschi,et al.  A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam , 2018, Molecules.

[16]  M. Hall,et al.  Biocatalytic reduction of activated CC-bonds and beyond: emerging trends. , 2018, Current opinion in chemical biology.

[17]  Michael J. Fink,et al.  Escherichia coli Fails to Efficiently Maintain the Activity of an Important Flavin Monooxygenase in Recombinant Overexpression , 2017, Front. Microbiol..

[18]  A. Westphal,et al.  Old Yellow Enzyme-Catalysed Asymmetric Hydrogenation: Linking Family Roots with Improved Catalysis , 2017 .

[19]  S. Hoebenreich,et al.  Revealing Additional Stereocomplementary Pairs of Old Yellow Enzymes by Rational Transfer of Engineered Residues , 2017, Chembiochem : a European journal of chemical biology.

[20]  A. Merschaert,et al.  A Biocatalytic Route to the Novel Antiepileptic Drug Brivaracetam , 2016 .

[21]  D. Ollis,et al.  Directed Evolution of Enzymes for Industrial Biocatalysis , 2016, Chembiochem : a European journal of chemical biology.

[22]  M. Hall,et al.  Enzymatic Synthesis of Optically Active Lactones via Asymmetric Bioreduction using Ene‐Reductases from the Old Yellow Enzyme Family , 2015 .

[23]  Philippe Ryvlin,et al.  Epilepsy: new advances , 2015, The Lancet.

[24]  Tao Chen,et al.  Metabolic engineering of Escherichia coli for the production of riboflavin , 2014, Microbial Cell Factories.

[25]  Georg Steinkellner,et al.  Identification of promiscuous ene-reductase activity by mining structural databases using active site constellations , 2014, Nature Communications.

[26]  M. Eadie,et al.  Shortcomings in the current treatment of epilepsy , 2012, Expert review of neurotherapeutics.

[27]  Jan M. L. Martin,et al.  “Turning Over” Definitions in Catalytic Cycles , 2012 .

[28]  Jie Ren,et al.  Biochemical characterization and substrate profiling of a new NADH-dependent enoate reductase from Lactobacillus casei. , 2012, Enzyme and microbial technology.

[29]  A. Bommarius,et al.  Asymmetric bioreduction of alkenes using ene-reductases YersER and KYE1 and effects of organic solvents. , 2011, Organic letters.

[30]  N. Scrutton,et al.  Focused Directed Evolution of Pentaerythritol Tetranitrate Reductase by Using Automated Anaerobic Kinetic Screening of Site‐Saturated Libraries , 2010, Chembiochem : a European journal of chemical biology.

[31]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[32]  M. Reetz,et al.  Directed Evolution of an Enantioselective Enoate-Reductase: Testing the Utility of Iterative Saturation Mutagenesis , 2009 .

[33]  N. Scrutton,et al.  Asymmetric Reduction of Activated Alkenes by Pentaerythritol Tetranitrate Reductase: Specificity and Control of Stereochemical Outcome by Reaction Optimisation. , 2009, Advanced synthesis & catalysis.

[34]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[35]  James H Naismith,et al.  An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol , 2008, BMC biotechnology.

[36]  B. Hauer,et al.  Asymmetric Bioreduction of Activated C=C Bonds Using Zymomonas mobilis NCR Enoate Reductase and Old Yellow Enzymes OYE 1–3 from Yeasts , 2008 .

[37]  Bernhard Hauer,et al.  Asymmetric Bioreduction of CC Bonds using Enoate Reductases OPR1, OPR3 and YqjM: Enzyme‐Based Stereocontrol , 2008 .

[38]  Bernhard Hauer,et al.  Asymmetric bioreduction of activated C=C bonds using enoate reductases from the old yellow enzyme family. , 2007, Current opinion in chemical biology.

[39]  N. Kubota,et al.  Stereoselective reduction of 2-butenolides to chiral butanolides by reductases from cultured cells of Glycine max , 2007 .

[40]  J. Stewart,et al.  Stereoselective enone reductions by Saccharomyces carlsbergensis old yellow enzyme , 2006 .

[41]  L. Lue,et al.  A molecular approach to bioseparations: Protein–protein and protein–salt interactions , 2006 .

[42]  M. Gillard,et al.  Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. , 2004, Journal of medicinal chemistry.